CN104302651B - 锗的配位化合物、其生产方法和药物 - Google Patents
锗的配位化合物、其生产方法和药物 Download PDFInfo
- Publication number
- CN104302651B CN104302651B CN201280073187.7A CN201280073187A CN104302651B CN 104302651 B CN104302651 B CN 104302651B CN 201280073187 A CN201280073187 A CN 201280073187A CN 104302651 B CN104302651 B CN 104302651B
- Authority
- CN
- China
- Prior art keywords
- germanium
- guanine
- acyclovir
- coordination compound
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H23/00—Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/52—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an inorganic compound, e.g. an inorganic ion that is complexed with the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/547—Chelates, e.g. Gd-DOTA or Zinc-amino acid chelates; Chelate-forming compounds, e.g. DOTA or ethylenediamine being covalently linked or complexed to the pharmacologically- or therapeutically-active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/30—Germanium compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Inorganic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2012120329 | 2012-05-16 | ||
| RU2012120329/04A RU2487878C1 (ru) | 2012-05-16 | 2012-05-16 | Комплексные соединения германия с производными азотистых оснований пуринового ряда, способы их получения и содержащие их лекарственные средства |
| PCT/RU2012/000897 WO2013172732A1 (ru) | 2012-05-16 | 2012-11-01 | Комплексные соединения германия, способы их получения и лекарственные средства |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104302651A CN104302651A (zh) | 2015-01-21 |
| CN104302651B true CN104302651B (zh) | 2017-04-12 |
Family
ID=48791166
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201280073187.7A Active CN104302651B (zh) | 2012-05-16 | 2012-11-01 | 锗的配位化合物、其生产方法和药物 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9745337B2 (https=) |
| EP (1) | EP2851368B1 (https=) |
| JP (1) | JP5993088B2 (https=) |
| KR (1) | KR101717280B1 (https=) |
| CN (1) | CN104302651B (https=) |
| AU (1) | AU2012380376B2 (https=) |
| BR (1) | BR112014027919B1 (https=) |
| CA (1) | CA2873390C (https=) |
| DK (1) | DK2851368T3 (https=) |
| ES (1) | ES2710915T3 (https=) |
| IN (1) | IN2014DN09234A (https=) |
| PL (1) | PL2851368T3 (https=) |
| PT (1) | PT2851368T (https=) |
| RU (1) | RU2487878C1 (https=) |
| TR (1) | TR201901561T4 (https=) |
| WO (1) | WO2013172732A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2626954C2 (ru) * | 2015-11-11 | 2017-08-02 | Общество С Ограниченной Ответственностью "Вдс Фарма" | Комплексные соединения германия с аминокислотами и липоевой кислотой |
| RU2752934C1 (ru) * | 2020-10-16 | 2021-08-11 | Александр Дмитриевич Исаев | Комплексные соединения германия с ациклическими полиолами и способ их получения |
| CN114133398B (zh) * | 2021-12-31 | 2022-11-22 | 中南民族大学 | 氨基酸取代的阿昔洛韦类三环核苷衍生物及其合成方法和应用 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0091114A1 (de) * | 1982-04-06 | 1983-10-12 | SANUM-KEHLBECK GmbH & Co. KG | Pharmazeutisch wirksame organische Germaniumverbindungen |
| CN1154359A (zh) * | 1996-01-12 | 1997-07-16 | 常达正 | 氨基酸锗的制备方法及其应用 |
| RU2104032C1 (ru) * | 1997-03-11 | 1998-02-10 | Общество с ограниченной ответственностью "Снежный барс" | Способ усиления лечебного эффекта лекарственных средств |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3616208A (en) * | 1967-09-29 | 1971-10-26 | Parke Davis & Co | Fermentation process for 9-(beta-d-arabinofuranosyl)adenine |
| JPS4924213B1 (https=) * | 1969-04-02 | 1974-06-21 | ||
| JPS4924213A (https=) | 1972-06-19 | 1974-03-04 | ||
| EP0477871A3 (en) | 1990-09-28 | 1992-12-02 | Nippon Kayaku Kabushiki Kaisha | Antiviral composition, containing guanine derivatives |
| AU706703B2 (en) * | 1996-09-05 | 1999-06-24 | Primamedic Limited | 1,3-dicarboxylic germanium complex and its therapeutic use |
| WO2000010561A1 (en) * | 1998-08-17 | 2000-03-02 | Evgeny Vladimirovich Soloviev | Bio-chemical germanium complexes with high therapeutic efficiency and wide application spectrum |
| ATE226441T1 (de) | 1999-02-22 | 2002-11-15 | Gernot Treusch | Therapeutisch wirksames stoffgemisch enthaltend s-acetylglutathion und aciclovir |
| RU2240792C2 (ru) | 2002-07-30 | 2004-11-27 | Государственное учреждение Научно-исследовательский институт вирусологии им. Д.И. Ивановского РАМН | Комбинации на основе нетропсина или его бис-производного, обладающие антигерпетической активностью |
| RU2233280C1 (ru) | 2003-03-25 | 2004-07-27 | Научно-исследовательский институт физической и органической химии Ростовского государственного университета | СОЛИ-10-ω-АРИЛОКСИАЛКИЛ-2,3,4,10-ТЕТРАГИДРОПИРИМИДО[1,2-A]БЕНЗИМИДАЗОЛА, ОБЛАДАЮЩИЕ МЕСТНОАНЕСТЕЗИРУЮЩИМ ДЕЙСТВИЕМ |
| DE10343365A1 (de) | 2003-09-17 | 2005-04-14 | Biosphings Ag | Pharmazeutische Formulierungen von Xanthogenaten und Hemmstoffen der viralen Nukleinsäurereplikation |
| RU2476436C1 (ru) * | 2012-01-25 | 2013-02-27 | Общество С Ограниченной Ответственностью "Вдс Фарма" | Комплексные соединения германия с аминокислотами и карбоновыми кислотами |
-
2012
- 2012-05-16 RU RU2012120329/04A patent/RU2487878C1/ru active
- 2012-11-01 AU AU2012380376A patent/AU2012380376B2/en not_active Ceased
- 2012-11-01 EP EP12876796.9A patent/EP2851368B1/en active Active
- 2012-11-01 JP JP2015512600A patent/JP5993088B2/ja active Active
- 2012-11-01 IN IN9234DEN2014 patent/IN2014DN09234A/en unknown
- 2012-11-01 PT PT12876796T patent/PT2851368T/pt unknown
- 2012-11-01 CN CN201280073187.7A patent/CN104302651B/zh active Active
- 2012-11-01 TR TR2019/01561T patent/TR201901561T4/tr unknown
- 2012-11-01 DK DK12876796.9T patent/DK2851368T3/en active
- 2012-11-01 ES ES12876796T patent/ES2710915T3/es active Active
- 2012-11-01 BR BR112014027919A patent/BR112014027919B1/pt active IP Right Grant
- 2012-11-01 CA CA2873390A patent/CA2873390C/en not_active Expired - Fee Related
- 2012-11-01 US US14/400,081 patent/US9745337B2/en active Active
- 2012-11-01 PL PL12876796T patent/PL2851368T3/pl unknown
- 2012-11-01 KR KR1020147035216A patent/KR101717280B1/ko active Active
- 2012-11-01 WO PCT/RU2012/000897 patent/WO2013172732A1/ru not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0091114A1 (de) * | 1982-04-06 | 1983-10-12 | SANUM-KEHLBECK GmbH & Co. KG | Pharmazeutisch wirksame organische Germaniumverbindungen |
| CN1154359A (zh) * | 1996-01-12 | 1997-07-16 | 常达正 | 氨基酸锗的制备方法及其应用 |
| RU2104032C1 (ru) * | 1997-03-11 | 1998-02-10 | Общество с ограниченной ответственностью "Снежный барс" | Способ усиления лечебного эффекта лекарственных средств |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2851368A1 (en) | 2015-03-25 |
| JP5993088B2 (ja) | 2016-09-14 |
| WO2013172732A1 (ru) | 2013-11-21 |
| KR101717280B1 (ko) | 2017-03-17 |
| IN2014DN09234A (https=) | 2015-07-10 |
| US9745337B2 (en) | 2017-08-29 |
| ES2710915T3 (es) | 2019-04-29 |
| PT2851368T (pt) | 2019-02-11 |
| EP2851368B1 (en) | 2019-01-02 |
| CN104302651A (zh) | 2015-01-21 |
| BR112014027919A2 (pt) | 2017-06-27 |
| CA2873390C (en) | 2017-10-24 |
| PL2851368T3 (pl) | 2019-06-28 |
| DK2851368T3 (en) | 2019-02-25 |
| TR201901561T4 (tr) | 2019-02-21 |
| BR112014027919B1 (pt) | 2020-02-04 |
| EP2851368A4 (en) | 2016-02-10 |
| US20150126726A1 (en) | 2015-05-07 |
| AU2012380376B2 (en) | 2015-10-01 |
| RU2487878C1 (ru) | 2013-07-20 |
| JP2015518823A (ja) | 2015-07-06 |
| KR20150011386A (ko) | 2015-01-30 |
| CA2873390A1 (en) | 2013-11-21 |
| AU2012380376A1 (en) | 2014-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI796665B (zh) | 1'-氰基經取代碳核苷類似物之吸入式調配物 | |
| JP2020509991A (ja) | Ｎ−［５−（アミノスルホニル）−４−メチル−１，３−チアゾール−２−イル］−ｎ−メチル−２−［４−（２−ピリジニル）−フェニル］−アセトアミド遊離塩基半水和物、製造方法およびその用途 | |
| JPH031309B2 (https=) | ||
| ES2877854T3 (es) | Una sal de maleato de la base libre de N-[5-(aminosulfonil)-4-metil-1,3-tiazol-2-il]-N-metil-2-[4-(2-piridinil)-fenil]-acetamida, formulaciones farmacéuticas, procedimientos de fabricación y usos de las mismas para el tratamiento de los virus del herpes | |
| CN104302651B (zh) | 锗的配位化合物、其生产方法和药物 | |
| JP2724711B2 (ja) | 医薬品生成物 | |
| PL190505B1 (pl) | Kompozycja farmaceutyczna i sposób jej wytwarzania | |
| CN103330687B (zh) | 稳定的更昔洛韦冻干粉针剂 | |
| KR20020041451A (ko) | 세포내 원핵생물, ｄｎａ 바이러스 및 레트로바이러스에의한 감염을 치료하기 위한 3-히드록시-4-피론의 갈륨착물 | |
| JP7576336B2 (ja) | １６α－ブロモ－３β－ヒドロキシ－５α－アンドロスタン－１７－ケトンおよびその水和物、誘導体および類似体を含む水性懸濁液組成物、製剤および水分散性乾燥組成物 | |
| US10045984B2 (en) | Combination therapy | |
| CN104940185B (zh) | 刺芒柄花素的医药用途 | |
| EP0082667A1 (en) | Pharmaceutical compositions | |
| US11202774B2 (en) | 5-substituted 2,4-thiazolidinediones (thiohydantoins), pseudothiohydantoins, and propseudothiohydantoins for use as antiviral agents | |
| US4230725A (en) | Antiviral agent | |
| EP3661937B1 (en) | Crystalline forms of ethyl ((s)-((((2r,5r)-5-(6-amino-9h-purin-9-yl)-4-fluoro-2,5-dihydrofuran-2-yl)oxy)methyl)(phenoxy)phosphoryl)-l-alaninate (gs-9131) for treating viral infections | |
| CN104940176A (zh) | 苦参啶的医药用途 | |
| US20060257432A1 (en) | Pharmaceutical formulations of xanthogenates and inhibitors of viral nucelic acid replication | |
| CN1491111A (zh) | 抗病毒方法的应用 | |
| HK40025637B (en) | Crystalline forms of ethyl ((s)-((((2r,5r)-5-(6-amino-9h-purin-9-yl)-4-fluoro-2,5-dihydrofuran-2-yl)oxy)methyl)(phenoxy)phosphoryl)-l-alaninate (gs-9131) for treating viral infections | |
| HK40025637A (en) | Crystalline forms of ethyl ((s)-((((2r,5r)-5-(6-amino-9h-purin-9-yl)-4-fluoro-2,5-dihydrofuran-2-yl)oxy)methyl)(phenoxy)phosphoryl)-l-alaninate (gs-9131) for treating viral infections | |
| WO1998003176A1 (en) | Treatment of feline infections peritonitis by an antiviral |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |